scholarly journals Use of Behavioral Change Techniques in Web-Based Self-Management Programs for Type 2 Diabetes Patients: Systematic Review

2013 ◽  
Vol 15 (12) ◽  
pp. e279 ◽  
Author(s):  
Michael van Vugt ◽  
Maartje de Wit ◽  
Wilmy HJJ Cleijne ◽  
Frank J Snoek
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Behavioral Change ◽  
Self Management ◽  
Web Based ◽  
Behavioral Change Techniques ◽  
Diabetes Patients

scholarly journals Self‐management among type 2 diabetes patients via the WeChat application: A systematic review and meta‐analysis

2020 ◽  
Vol 46 (1) ◽  
pp. 4-16
Author(s):  
Jing Yang ◽  
Hui Yang ◽  
Zihui Wang ◽  
Xin Wang ◽  
Yingkai Wang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Self Management ◽  
Diabetes Patients

Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c

2021 ◽  
Author(s):  
Ana Paula Delgado Bomtempo Batalha ◽  
Isabela Coelho Ponciano ◽  
Gabriela Chaves ◽  
Diogo Carvalho Felício ◽  
Raquel Rodrigues Britto ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Behavior Change ◽  
Self Management ◽  
Behavior Change Interventions

scholarly journals Management of Chronic Disease and Hospitalization Due to Diabetes among Type 2 Diabetes Patients in Korea: Using the National Sample Cohort Data 2002–2013

2018 ◽  
Vol 15 (11) ◽  
pp. 2541
Author(s):  
Sang Lee ◽  
Woorim Kim ◽  
Sarah Oh ◽  
Jieun Yang ◽  
Jieun Jang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Disease ◽  
National Sample ◽  
Self Management ◽  
Management Skills ◽  
Cohort Data ◽  
Onset Of Diabetes ◽  
Cox Proportional Hazard Regression ◽  
Diabetes Patients

To prevent negative outcomes for diabetes patients, developing self-management skills is imperative. This study aimed to examine the association between management of chronic disease (MCD), which mainly involves educating patients about their chronic diseases for obtaining self-management skills and hospitalization due to diabetes among type 2 diabetes patients in Korea. Korean National Health Insurance Service National Sample Cohort data from 2002 to 2013 were used. A total of 54,031 type 2 diabetes patients were included in the study. If patients received the MCD within 1 year from the onset of diabetes, we categorized them as “MCD received patients” We reclassified these groups into five groups: “non-receiving”, “1–3 times”, “4–6 times”, “7–9 times” and “10–12 times” The dependent variable of this study was hospitalization due to diabetes. Cox proportional hazard regression was used. Of the patients, 86.2% (n = 46,571) did not received the MCD within the 1 year from the onset of diabetes. The number of MCDs received increased and the hazard ratio (HR) for hospitalization due to diabetes decreased; particularly, patients who received MCD 10–12 times per annum showed the lowest HR for hospitalization due to diabetes compared to patients in the MCD non-received group (1–3 times per annum: HR: 0.81, p = 0.0001; 4–6 times per annum: HR: 0.82, p = 0.0248; 7–9 times per annum: HR: 0.75, p = 0.0054; 10–12 times per annum: HR: 0.61, p < 0.0001). Considering the importance of raising self-managing diabetes skills, the findings can aid in determining the outcomes of the MCD program.

scholarly journals Triangulating evidence for the causal impact of single-dose zinc supplement on glycemic control for type-2 diabetes

2021 ◽  
Author(s):  
Zhiyang Wang ◽  
Carine Ronsmans ◽  
Benjamin Woolf
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Glycemic Control ◽  
Fasting Glucose ◽  
Causal Effect ◽  
Fasting Blood Glucose ◽  
Zinc Supplement ◽  
Diabetes Patients

Background: Although previous studies suggested the protective effect of zinc for type-2 diabetes, the unitary causal effect remains inconclusive. Objective: We investigated the causal effect of zinc as a single intervention on glycemic control in type-2 diabetes patients, using a systematic review of RCTs and two-sample Mendelian randomization (MR). Methods: Four outcomes were identified: fasting blood glucose/fasting glucose, hemoglobin A1c (HbA1c), homeostasis model assessment of insulin resistance (HOMA-IR), and serum insulin/fasting insulin level. In the systematic review, four databases were searched up to June 2021. Results were synthesized through the random-effects meta-analysis. Single nucleotide polymorphisms (SNPs) that are independent and are strongly related to zinc supplements were selected from MR-base to perform the two-sample MR with inverse-variance weighted (IVW) coefficient. Results: In the systematic review, 14 trials were included. The zinc supplement led to a significant reduction in the post-trial mean of fasting blood glucose (mean difference (MD): -26.52, 95%CI: -35.13, -17.91), HbA1C (MD: -0.52, 95%CI: -0.90, -0.13), and HOMA-IR (MD: -1.65, 95%CI: -2.62, -0.68), compared to the control group. In the two-sample MR, zinc supplement with 2 SNPs associated with lower fasting glucose (IVW coefficient: -2.04, 95%CI: -3.26, -0.83), but not specified type-2 diabetes. Conclusion: Although the study was limited by the few trials (review) and SNPs (two-sample MR), we demonstrated that the single zinc supplementary improved glycemic control among type-2 diabetes patients with causal evidence to a certain extent.

Sign in / Sign up

Export Citation Format

Share Document